Skip to main content
. 2020 Dec 15;11:579206. doi: 10.3389/fphar.2020.579206

GRAPHICAL ABSTRACT.

GRAPHICAL ABSTRACT

Escitalopram alleviates HFFD/STZ-induced metabolic and cardiac derangements in type 2 diabetic rats. BG: blood glucose, BW: body weight, ECG: electrocardiographic, HFFD: high fat-high fructose diet, HOMA-IR: homeostasis model assessment of insulin resistance, HR: heart rate, MHC: myosin heavy chain, NADPH oxidase: nicotinamide adenine dinucleotide phosphate oxidase, NF-κB: nuclear factor-kappa B, RAGE: receptor for advanced glycation end products, STZ: streptozotocin, TAC: total antioxidant capacity, TC: total cholesterol, TGF-β: transforming growth factor-beta, TGs: triglycerides, TNF-α: tumor necrosis factor-alpha.